News Briefing channel feed – Endpoints News

News Briefing channel feed

Merck pours $400M into flea drugs for Fido; Avrobio shows durability; Rhythm gets priority review

5 years ago

Chinese biotech aims $232M in IPO cash to push next-gen prostate cancer drug; Immunomedics raises nearly a half-billion off approval

5 years ago

Fritz Gerber, who led Roche for 2 decades, dies; ADC Therapeutics tries again for an IPO, sets terms

5 years ago

A new player enters the KRAS game with Fortress; Gilead picks up once-failed cancer drug from Mologen's fire sale

6 years ago

Another sparse round of NASH data; TG raises $60M after PhIII success

6 years ago

Adverum soars on early gene therapy data; BerGenBio raises €45.4M on the heels of Covid-19 move

6 years ago

New Darzalex formulation wins FDA approval; Israeli biotech plans $50M IPO

6 years ago

EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more

6 years ago

Vertex lavishes $80M cash to expand gene therapy tool kit; Supernus bags a $300M CNS portfolio

6 years ago

AstraZeneca, GSK reiterate 2020 outlook; Shanghai biotech I-Mab is looking for a US partner — report

6 years ago

Astellas partners with Insilico, Harvard; Zambon gets FDA's fast track status for lung drug

6 years ago

Regeneron/Sanofi PD-1 trial halted for significant efficacy; Avadel soars on positive narcolepsy data

6 years ago

An upsized IPO? In this economy? Of course; Sofinnova and AbbVie lead $38M Series A for Parkinson’s startup

6 years ago

EMA approves Boehringer's systemic sclerosis therapy; Novartis' Kymriah wins RMAT status for follicular lymphoma

6 years ago

Sangamo ties up with a newcomer in the cell therapy field; LabCorp wins FDA authorization of latest Covid-19 test

6 years ago

Sofinnova Telethon Fund backs Naldini's gene therapy biotech; ORIC prices $75M IPO

6 years ago

Galapagos finds Polish partner for inflammation drugs; Zai Lab's Zejula app gets speedy review in China

6 years ago

Merck launches the latest Herceptin knockoff; Harvard spinout grabs a $5M seed round

6 years ago

Alnylam's new pipeline star gets on FDA fast track; ARCH-backed biotech nabs orphan drug status

6 years ago

Pfizer nabs colorectal cancer OK for Braftovi; Bristol Myers, Pfizer pull out of regional deal with Portola

6 years ago

Keytruda nabs another priority review; Quell ties up CAR pact with Hannover Medical School

6 years ago

Wellcome looks for backers of an $8B-plus Covid-19 fund; ReNeuron signs on another pharma partner

6 years ago

Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T

6 years ago

Flexion secures China deal for osteoarthritis drug; Struggling to find a buyer, Akorn throws in the towel

6 years ago

First page Previous page 40 41 424344 45 46 Next page Last page